Search

Author/Creator Grever, Michael R.

1. A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high‐risk myelodysplastic syndrome. Issue 12 (19th September 2020)

Authors:
Saygin, Caner; Larkin, Karilyn; Blachly, James S.; Orwick, Shelley; Ngankeu, Apollinaire; Gregory, Charles T.; Phelps, Mitch A.; Mani, Shylaja; Walker, Alison; Garzon, Ramiro; Vasu, Sumithira; Walsh, Katherine J.; Bhatnagar, Bhavana; Klisovic, Rebecca B.; Grever, Michael R.; Marcucci, Guido; Byrd...
Journal:
American journal of hematology
Issue:
Volume 95:Issue 12(2020:Dec.)
Page Start:
1457
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. BRAFV600E induces ABCB1/P-glycoprotein expression and drug resistance in B-cells via AP-1 activation. Issue 11 (November 2015)

Authors:
Tsai, Yo-Ting; Lozanski, Gerard; Lehman, Amy; Sass, Ellen J.; Hertlein, Erin; Salunke, Santosh B.; Chen, Ching-Shih; Grever, Michael R.; Byrd, John C.; Lucas, David M.
Journal:
Leukemia research
Issue:
Volume 39:Issue 11(2015:Nov.)
Page Start:
1270
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Externally validated predictive clinical model for untreated del(17p13.1) chronic lymphocytic leukemia patients. Issue 11 (12th October 2015)

Authors:
Stephens, Deborah M.; Ruppert, Amy S.; Weirda, William G.; Jones, Jeffrey A.; Woyach, Jennifer A.; Maddocks, Kami; Jaglowski, Samantha M.; Andritsos, Leslie A.; Flynn, Joseph M.; Grever, Michael R.; Lozanski, Gerard; Tam, Constantine; O'Brien, Susan; Keating, Michael J.; Muthusamy, Natarajan; Abr...
Journal:
American journal of hematology
Issue:
Volume 90:Issue 11(2015:Nov.)
Page Start:
967
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Final results of EFC6663: A multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia. Issue 5 (May 2015)

Authors:
Lanasa, Mark C.; Andritsos, Leslie; Brown, Jennifer R.; Gabrilove, Janice; Caligaris-Cappio, Federico; Ghia, Paolo; Larson, Richard A.; Kipps, Thomas J.; Leblond, Veronique; Milligan, Donald W.; Janssens, Ann; Johnson, Amy J.; Heerema, Nyla A.; Bühler, Andreas; Stilgenbauer, Stephan; Devin, Jeann...
Journal:
Leukemia research
Issue:
Volume 39:Issue 5(2015:May)
Page Start:
495
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Flavopiridol can be safely administered using a pharmacologically derived schedule and demonstrates activity in relapsed and refractory non‐Hodgkin's lymphoma. Issue 1 (30th September 2013)

Authors:
Jones, Jeffrey A.; Rupert, Amy S.; Poi, Ming; Phelps, Mitch A.; Andritsos, Leslie; Baiocchi, Robert; Benson, Don M.; Blum, Kristie A.; Christian, Beth; Flynn, Joseph; Penza, Sam; Porcu, Pierluigi; Grever, Michael R.; Byrd, John C.
Journal:
American journal of hematology
Issue:
Volume 89:Issue 1(2014:Jan.)
Page Start:
19
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinib. Issue 1 (20th October 2022)

Authors:
Kittai, Adam S.; Huang, Ying; Beckwith, Kyle A.; Bhat, Seema A.; Bond, David A.; Byrd, John C.; Goldstein, Daniel; Grever, Michael R.; Miller, Cecelia; Rogers, Kerry A.; Yano, Max; Woyach, Jennifer A.
Journal:
American journal of hematology
Issue:
Volume 98:Issue 1(2023)
Page Start:
56
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗